Search results for "breakpoint"

showing 10 items of 70 documents

Reference growth charts for Posidonia oceanica seagrass: An effective tool for assessing growth performance by age and depth

2016

Abstract Growth performance of rhizomes has become among the most used descriptors for monitoring Posidonia oceanica seagrass dynamics and population status. However, ability to detect any change of growth in space or in time is often confounded by natural age-induced decline. To overcome this problem, we have produced reference growth charts, which in other areas are universally recognized as a very powerful tool for comparing growth of living beings during their ontogeny. Reference growth charts involving different P. oceanica growth performance measures (speed of growth and primary production of rhizomes) have been built using proper statistical frameworks (GLMM, Segmented and Quantile R…

0106 biological sciencesPercentileAgingDating methodGeneral Decision Sciences010603 evolutionary biology01 natural sciencesMediterranean seaAquatic plant ecologyStatisticsRange (statistics)ConfoundingSegmented regressionSeagrasseEcology Evolution Behavior and SystematicsbiologyEcologyEcologyLepidochronology010604 marine biology & hydrobiologybiology.organism_classificationSeagrassSegmented regressionDecision Sciences (all)Posidonia oceanicaShootBreakpointGLMMQuantile
researchProduct

Computational Prediction of Position Effects of Apparently Balanced Human Chromosomal Rearrangements.

2017

Interpretation of variants of uncertain significance, especially chromosomal rearrangements in non-coding regions of the human genome, remains one of the biggest challenges in modern molecular diagnosis. To improve our understanding and interpretation of such variants, we used high-resolution three-dimensional chromosomal structural data and transcriptional regulatory information to predict position effects and their association with pathogenic phenotypes in 17 subjects with apparently balanced chromosomal abnormalities. We found that the rearrangements predict disruption of long-range chromatin interactions between several enhancers and genes whose annotated clinical features are strongly …

0301 basic medicineCandidate genediagnosis030105 genetics & heredityMedical and Health SciencescytogeneticsTranslocation Geneticchromosomal translocationChromosome Breakpointschromatin conformationbalanced chromosomal rearrangement2.1 Biological and endogenous factorsChromosomes HumanGenetics(clinical)AetiologyGenetics (clinical)In Situ HybridizationIn Situ Hybridization Fluorescencelong-range effectGeneticsGenetics & HeredityGene RearrangementGenomeChromosome MappingBiological SciencesChromatinPosition effectPhenotypeMedical geneticsHPOHumandistal effectmedicine.medical_specialtyChromosome engineeringchromosomal rearrangement/dk/atira/pure/subjectarea/asjc/1300/1311KaryotypeTranslocationChromosomal rearrangementBiologyChromosomesFluorescenceArticleChromosomal Position Effects03 medical and health sciencesGeneticClinical ResearchmedicineGeneticsHumansGenetic Predisposition to DiseaseGeneGenome HumanHuman GenomeGenetic Variation/dk/atira/pure/subjectarea/asjc/2700/2716030104 developmental biologyGene Expression RegulationHuman genomeclinical geneticsAmerican journal of human genetics
researchProduct

The IgG1 B-cell receptor provides survival and proliferative signals analogue to the Igα but not the Igβ co-receptor.

2016

The function of the IgM B-cell receptor (BCR) is dependent on intact signaling of the co-receptors Igα and Igβ, both of which contain a cytoplasmic tail bearing an immunoreceptor tyrosine-based activation motif. We have previously demonstrated that the cytoplasmic tail of the IgG1 BCR can partially compensate for the loss of the signaling moiety of Igα. Here, we show that unlike Igα, Igβ signaling is indispensable for the development and function of IgG1-expressing B cells. Deletion of the cytoplasmic signaling tail of Igβ compromised the survival and proliferation not only of IgM(+) B cells but also of IgG1-expressing B cells. In the absence of the signaling tail of Igβ, the transcription …

0301 basic medicineCo-receptorImmunologyB-cell receptorbcl-X ProteinReceptors Antigen B-CellBiologyCell Line03 medical and health sciencesTransduction (genetics)Mice0302 clinical medicineTranscription (biology)Immunology and AllergyAnimalsCyclin D2TyrosineReceptorCell ProliferationB-Lymphocytesbreakpoint cluster regionFlow CytometryCell biology030104 developmental biologyImmunoglobulin MCytoplasmImmunoglobulin GCancer researchCD79 Antigens030215 immunologySignal TransductionEuropean journal of immunology
researchProduct

CLOVE: classification of genomic fusions into structural variation events

2017

Background A precise understanding of structural variants (SVs) in DNA is important in the study of cancer and population diversity. Many methods have been designed to identify SVs from DNA sequencing data. However, the problem remains challenging because existing approaches suffer from low sensitivity, precision, and positional accuracy. Furthermore, many existing tools only identify breakpoints, and so not collect related breakpoints and classify them as a particular type of SV. Due to the rapidly increasing usage of high throughput sequencing technologies in this area, there is an urgent need for algorithms that can accurately classify complex genomic rearrangements (involving more than …

0301 basic medicineGenomicsBiologycomputer.software_genrelcsh:Computer applications to medicine. Medical informaticsBiochemistryChromosomesDNA sequencingSet (abstract data type)Structural variationUser-Computer Interface03 medical and health sciencesStructural BiologyEscherichia coliHumansCopy-number variationMolecular Biologylcsh:QH301-705.5InternetMethodology ArticleApplied MathematicsBreakpointGenomic rearrangementsDNAGenomicsStructural variationsComputer Science ApplicationsIdentification (information)030104 developmental biologylcsh:Biology (General)Nucleic Acid ConformationGraph (abstract data type)lcsh:R858-859.7Data miningcomputerAlgorithmsBMC Bioinformatics
researchProduct

2018

The IgMi mouse fails to secrete antibodies or class switch its BCR from IgM. Our study reveals that other cellular compartments, including B-cell subsets, DC subsets, GC B cells and TFH cells are perturbed in the IgMi mouse, thus presenting important additional considerations when using the mouse to explore the role of secreted antibody.

0301 basic medicineImmunologyB cell biologybreakpoint cluster regionBiologyCell biology03 medical and health sciences030104 developmental biology0302 clinical medicinebiology.proteinImmunology and AllergySecretionAntibodyCellular compartment030215 immunologyEuropean Journal of Immunology
researchProduct

HSP110 sustains chronic NF-κB signaling in activated B cell diffuse large B cell lymphoma through MyD88 stabilization

2018

International audience; Activated B cell diffuse large B cell lymphoma (ABC-DLBCL) is an aggressive lymphoproliferative disorder involving chronic NF-κB activation. Several mutations in the BCR and the MyD88 signaling pathway components, such as MyD88 L265P, are implicated in this aberrant activation. Among heat-shock proteins, HSP110 has recently been identified as a pro- survival and/or proliferation factor in many cancers but its role in ABC-DLBCL survival mechanisms remained to be established. We observed that shRNA-mediated HSP110 silencing decreased the survival of several ABC-DLBCL cell lines, decreased IgM-MyD88 co-localization and subsequent NF-κB signaling. Conversely, over-expres…

0301 basic medicineImmunology[SDV.CAN]Life Sciences [q-bio]/CancerBiochemistry[ SDV.CAN ] Life Sciences [q-bio]/CancerCohort Studies03 medical and health sciencesimmune system diseaseshemic and lymphatic diseasesmedicineTumor Cells CulturedGene silencingHumansHSP110 Heat-Shock ProteinsB cellChemistryProtein StabilityWild typebreakpoint cluster regionNF-kappa BCell BiologyHematologymedicine.disease3. Good healthLymphoma030104 developmental biologymedicine.anatomical_structureCell cultureMyeloid Differentiation Factor 88Cancer researchLymphoma Large B-Cell DiffuseSignal transductionDiffuse large B-cell lymphomaSignal Transduction
researchProduct

Detailed analysis of inversions predicted between two human genomes: errors, real polymorphisms, and their origin and population distribution.

2016

The growing catalogue of structural variants in humans often overlooks inversions as one of the most difficult types of variation to study, even though they affect phenotypic traits in diverse organisms. Here, we have analysed in detail 90 inversions predicted from the comparison of two independently assembled human genomes: the reference genome (NCBI36/HG18) and HuRef. Surprisingly, we found that two thirds of these predictions (62) represent errors either in assembly comparison or in one of the assemblies, including 27 misassembled regions in HG18. Next, we validated 22 of the remaining 28 potential polymorphic inversions using different PCR techniques and characterized their breakpoints …

0301 basic medicinePopulationBiologyGenomeEvolution Molecular03 medical and health sciencesGeneticsHumans1000 Genomes ProjectAlleleSelection GeneticeducationMolecular BiologyAllele frequencyGenetics (clinical)Geneticseducation.field_of_studyPolymorphism GeneticGenome HumanSequence InversionBreakpointMolecular Sequence AnnotationGeneral MedicineSequence Analysis DNA030104 developmental biologyChromosome InversionHuman genomeReference genomeHuman molecular genetics
researchProduct

The B-cell receptor in control of tumor B-cell fitness: Biology and clinical relevance

2019

Surface expression of a functional B cell antigen receptor (BCR) is essential for the survival and proliferation of mature B cells. Most types of B-cell lymphoproliferative disorders retain surface BCR expression, including B-cell non-Hodgkin lymphomas (B-NHL) and chronic lymphocytic leukemia (CLL). Targeting BCR effectors in B-NHL cell lines in vitro has indicated that this signaling axis is crucial for malignant B cell growth. This has led to the development of inhibitors of BCR signaling, which are currently used for the treatment of CLL and several B-NHL subtypes. Recent studies based on conditional BCR inactivation in a MYC-driven mouse B-cell lymphoma model have revisited the role of …

0301 basic medicinetumor cell fitnessChronic lymphocytic leukemiaImmunologyB-cell receptorPopulationReceptors Antigen B-CellLymphoproliferative disorderslymphomaBiologyMice03 medical and health sciences0302 clinical medicineimmune system diseaseshemic and lymphatic diseasesB-cell receptorTumor MicroenvironmentmedicineAnimalsHumansImmunology and AllergyeducationHematologic NeoplasmB cellBCR inhibitorB-Lymphocyteseducation.field_of_studyAnimalB-Lymphocytebreakpoint cluster regionB-cell receptor; BCR inhibitors; c-MYC; lymphoma; lymphoma resistance; tumor cell fitnesslymphoma resistancemedicine.diseaseLymphoproliferative DisordersLymphomaBCR inhibitorsPhenotype030104 developmental biologymedicine.anatomical_structurec-MYCtumor cell fitneCell cultureLymphoproliferative DisorderHematologic NeoplasmsCancer researchHumanSignal Transduction030215 immunology
researchProduct

An Immunogenic Peptide Derived from NM23-H2 Is Expressed on Bcr/abl+ Cells.

2006

Abstract Objective: Most tumors express antigens which, when presented by MHC molecules, can be recognized by cytotoxic T-lymphocytes. These tumor-associated-antigens (TAA) are considered to be key determinants in the graft-versus-tumor effect after allogeneic hematopoietic cell transplantation (HCT) and are therefore potential candidates for tumor vaccination. Unfortunately only small numbers of TAA have been isolated to date. In this project we looked for immunogenic peptides presented by bcr/abl+ cells of an HLA-A32 CML patient. Methods: Leukemia-specific mixed lymphocyte leukemia cell cultures (MLLC) were generated by co-culturing irradiated bcr/abl+ cells from the patient with peripher…

ABLELISPOTLymphocyteImmunologybreakpoint cluster regionCell BiologyHematologyBiologyMajor histocompatibility complexBiochemistryMolecular biologymedicine.anatomical_structureAntigenhemic and lymphatic diseasesmedicinebiology.proteinCytotoxic T cellK562 cellsBlood
researchProduct

Identification of a Novel Pathway in BCR/ABL Signal Transduction Involving Akt-Independent Activation of PLC-gamma/mTOR/p70-S6K.

2006

Abstract In BCR/ABL positive CML, defining new, additional therapeutic targets in the pathways, activated by BCR/ABL is critical for the development of new treatment strategies, especially for patients resistant or refractory to Imatinib. While studying the involvement of PI3K/Akt/mTOR signaling pathway in the development of such resistance we have uncovered the existence of additional, Akt-independent mechanism of activation of mTOR/p70-S6 Kinase pathway. Short term treatment with Imatinib (1μM, 4 hours) of the BCR/ABL-positive cell lines LAMA84, AR320, KCL22, K562, Ba/F3-BCR/ABL caused downregulation of p70-S6K phosphorylation and of S6 ribosomal protein phosphorylation without decreasing…

ABLImmunologybreakpoint cluster regionP70-S6 Kinase 1Cell BiologyHematologyBiologyBiochemistryImatinib mesylatehemic and lymphatic diseasesCancer researchPhosphorylationProtein kinase BPI3K/AKT/mTOR pathwayK562 cellsBlood
researchProduct